BCAP31 and breast carcinoma: Our data showed that high BCAP31 expression was significantly associated with the molecular subtype of breast cancer (high BCAP31 expression in TNBC, Table 1), reduced OS (p = 0.0019), and reduced disease-free survival (DFS, p = 0.0411) in 186 breast cancer patients (Figure 2B).